SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 108,900
+1,900 (1.78%)
At close: Sep 5, 2025
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 8.55 trillion as of September 5, 2025. Its market cap has increased by 27.72% in one year.
Market Cap
8.55T
Enterprise Value
8.42T
Revenue
620.28B
Ranking
n/a
PE Ratio
33.41
Stock Price
108,900.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 8.55T, a decrease of -14.02%. That is a compound annual growth rate of -2.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 8,551.81B | -1.71% |
| Dec 30, 2024 | 8,700.60B | 10.66% |
| Dec 28, 2023 | 7,862.65B | 39.25% |
| Dec 29, 2022 | 5,646.39B | -25.82% |
| Dec 30, 2021 | 7,612.05B | -42.49% |
| Dec 30, 2020 | 13.23T | 33.07% |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.38T |
| Celltrion | 37.49T |
| ALTEOGEN | 24.98T |
| Yuhan | 8,835.06B |
| Peptron | 7,070.75B |
| PharmaResearch | 6,462.36B |
| LigaChem Biosciences | 5,432.65B |
| ABL Bio | 5,211.92B |